Antimicrobial Stewardship
Antimicrobial Stewardship
复制标题
DOI：
10.4065/mcp.2011.0358
复制
发表时间：
2011-11-01
影响因子：
8.9
通讯作者：
Davidson, Lisa E.
中科院分区：
文献类型：
--
作者：
Doron, Shira;Davidson, Lisa E.
抗生素耐药性正在增加;然而，抗微生物药物的开发正在放缓。现在比以往任何时候都更重要的是，抗菌药物管理是优化抗菌药物使用的一种方式，以防止耐药性的发展和改善患者的预后。本文综述了为什么，什么，谁，如何，何时，何地的抗菌药物管理。总结了管理的技术，并概述了管理计划的实施计划。
Antimicrobial resistance is increasing; however, antimicrobial drug development is slowing. Now more than ever before, antimicrobial stewardship is of the utmost importance as a way to optimize the use of antimicrobials to prevent the development of resistance and improve patient outcomes. This review describes the why, what, who, how, when, and where of antimicrobial stewardship. Techniques of stewardship are summarized, and a plan for implementation of a stewardship program Is outlined.